Treatment, ECOG PS at baseline, site of metastasis*treatment, sum of longest target lesion diameters, CRP, ALP, lymphocyte proportion in intratumoral stroma, TMB*treatment, and tumor CD8+ T‐cell infiltration*treatment. This evidence concerns the gene CD8A and neoplasm.